Related Experiment Video
Updated: Jan 13, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Evaluating the Diagnostic Utility of Cystatin C versus Creatinine in Chronic Kidney Disease: A Cross-Sectional
Pallavi Sagar1, Ravi Shekhar2, Bandana Kumari1
1Biochemistry, All India Institute of Medical Sciences, Patna, IND.
Insights
Serum cystatin C is a sensitive biomarker for chronic kidney disease (CKD) detection, showing better correlation with estimated glomerular filtration rate (eGFR) than creatinine. Integrating cystatin C can improve early CKD diagnosis in Indian patients.
Area of Science:
- Nephrology
- Biomarker Discovery
- Clinical Diagnostics
Background:
- Chronic kidney disease (CKD) is prevalent in India, often linked to diabetes and hypertension.
- Serum creatinine, a traditional biomarker, has limitations in early CKD detection due to non-renal factor influences.
- Serum cystatin C offers a promising alternative, unaffected by muscle mass or diet.
Purpose of the Study:
- To evaluate the diagnostic utility of serum cystatin C compared to serum creatinine for CKD detection and monitoring in Indian patients.
- To assess the correlation of cystatin C and creatinine with estimated glomerular filtration rate (eGFR).
Main Methods:
- A cross-sectional study involving 150 participants (75 CKD patients, 75 controls) at Indira Gandhi Institute of Medical Sciences, Patna.
- Serum cystatin C measured by ELISA; serum creatinine by kinetic Jaffe method.
- Calculated eGFR using CKD-EPI equations based on both biomarkers (eGFRCr-Cys, eGFRCr, eGFRCys).
Main Results:
- Both cystatin C and creatinine were significantly elevated in CKD patients (p<0.0001).
- Cystatin C demonstrated a stronger negative correlation with eGFRCr-Cys (r = -0.91) than creatinine (r = -0.896).
- High concordance (r = 0.90) between eGFRCr-Cys and eGFRCr was observed, especially in diabetic and early-stage CKD subgroups.
Conclusions:
- Serum cystatin C is a sensitive and reliable biomarker for CKD detection, outperforming creatinine in correlation with eGFRCr-Cys.
- Cystatin C is particularly valuable for early CKD diagnosis and in high-risk populations.
- Routine integration of cystatin C could enhance early diagnosis and patient outcomes, despite cost and availability barriers.
Background:
Chronic kidney disease (CKD) is a progressive condition with high prevalence in India, often driven by diabetes and hypertension. Early detection is critical, yet serum creatinine, the conventional biomarker, is influenced by non-renal factors and lacks sensitivity in early stages. Cystatin C, a low molecular weight protein unaffected by muscle mass or diet, has emerged as a promising alternative. This study evaluates the diagnostic utility of serum cystatin C versus creatinine in detecting and monitoring CKD among Indian patients.
Methods:
A cross-sectional observational study was conducted at Indira Gandhi Institute of Medical Sciences, Patna, over 18 months, enrolling 150 participants: 75 patients with CKD (grades 3-5) and 75 healthy controls. Serum cystatin C was measured using an enzyme-linked immunosorbent assay and serum creatinine via the kinetic Jaffe method. Estimated glomerular filtration rate (eGFR)Cr-Cys, eGFRCr, and eGFRCys were calculated using Chronic Kidney Disease Epidemiology Collaboration or CKD-EPI equations based on both biomarkers (serum creatinine and serum cystatin C). Statistical analyses were conducted using t-tests, chi-square tests, and Pearson correlation coefficients to compare biomarker levels and assess their relationship with eGFR.
Results:
Both serum cystatin C and creatinine were significantly elevated in patients with CKD compared to controls (p<0.0001). Cystatin C showed a stronger negative correlation with eGFRCr-Cys (r = -0.91) than creatinine (r = -0.896). A high concordance (r = 0.90) was observed between eGFR values derived from cystatin C and creatinine equations in patients with CKD, particularly in diabetic subgroups and early-stage CKD. In healthy controls, this correlation was weaker and non-significant.
Conclusion:
Serum cystatin C is a sensitive and reliable biomarker for CKD detection, demonstrating superior correlation with eGFRCr-Cys compared to creatinine. Its diagnostic performance is especially valuable in early-stage disease and high-risk populations. Integrating cystatin C into routine clinical practice could enhance early diagnosis and improve patient outcomes, though cost and assay availability remain barriers.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Serum Studies: Renal Function Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care

